TriSalus Life Sciences Warrant
TLSIW
22 hedge funds and large institutions have $3.72M invested in TriSalus Life Sciences Warrant in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 3 reducing their positions, and 2 closing their positions.
210% more capital invested
Capital invested by funds: $1.2M → $3.72M (+$2.52M)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
16% more funds holding
Funds holding: 19 → 22 (+3)
10.78% more ownership
Funds ownership: 0% → 10.78% (+11%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$45.8K |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$23.7K |
| 3 |
CS
Clear Street
New York
|
+$22.3K |
| 4 |
Walleye Trading
New York
|
+$19.1K |
| 5 |
FVWA
Foster Victor Wealth Advisors
Greenville,
South Carolina
|
+$5.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KL
KIM LLC
Wichita,
Kansas
|
-$34.7K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$29K |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
-$27K |
| 4 |
Walleye Capital
New York
|
-$12.2K |
| 5 |
Jane Street
New York
|
-$38 |
TLSIW Hedge Fund Activity: Q4 2023 in Review
22 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2023, worth a combined $3.72M — up 210% from $1.2M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TLSIW positions and 2 closed out — a net gain of 3 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $45.8K. The largest seller was KIM LLC, cutting an estimated $34.7K.
- 22 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2023, up from 19 in Q3 2023.
- Funds reported $3.72M of TriSalus Life Sciences Warrant stock for Q4 2023, up 210% quarter-over-quarter.
- 5 funds opened new TriSalus Life Sciences Warrant positions in Q4 2023 and 2 closed out, a net change of +3 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q4 2023 was Wolverine Asset Management, an estimated $45.8K added.
- The largest TriSalus Life Sciences Warrant seller in Q4 2023 was KIM LLC, an estimated $34.7K sold.
Based on aggregated 13F filings for Q4 2023.